Steven Kwan is day-to-day after receiving an injection in his sore right wrist during the All-Star break.

Scientists have developed a long-acting injectable treatment combining levodopa and carbidopa, the two medications used to treat Parkinson’s, which could transform how the disease is treated.

Proof-of-concept exploits have been released for a critical SQLi vulnerability in Fortinet FortiWeb that can be used to achieve pre-authenticated remote code execution on vulnerable servers.

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.

There are limited treatment options for cluster headache. In 2024, the FDA rejected the DHE mesylate auto-injector, citing problems after a facility inspection at a third-party site.

"Since we're going to be on this kind of, you know, throwing flowers around attitude, this man [points to Carpenter] has a record coming out much sooner, in August, that I just heard a few songs ...

A newly approved twice-yearly injection for HIV prevention has rejuvenated hope in the national and global drive to end HIV/Aids as a public health threat by 2030. Lenacapavir, the groundbreaking ...

Discover how sclerotherapy treats spider veins and small varicose veins. Read ahead to know more as an expert explains the process, benefits, and who should avoid it.

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.

Gilead's PrEP drug lenacapavir, to marketed under the name Yeztugo, provides six months protection from HIV with a single shot.

An Oklahoma judge granted a temporary stay of execution Monday to a man whose transfer to death row was expedited by the Trump administration and who was scheduled to receive a lethal injection on ...

To report the results of the multicenter, open-label IRAKLIA trial (ClinicalTrials.gov identifier: NCT05405166) of isatuximab subcutaneous (SC) versus intravenous (IV), plus pomalidomide and ...